p53-PGC-1 alpha Pathway Mediates Oxidative Mitochondrial Damage and Cardiomyocyte Necrosis Induced by Monoamine Oxidase-A Upregulation: Role in Chronic Left Ventricular Dysfunction in Mice
- 31 December 2012
- journal article
- research article
- Published by Mary Ann Liebert Inc in Antioxidants and Redox Signaling
- Vol. 18 (1), 5-18
- https://doi.org/10.1089/ars.2011.4373
Abstract
Aims: Oxidative stress and mitochondrial dysfunction participate together in the development of heart failure (HF). mRNA levels of monoamine oxidase-A (MAO-A), a mitochondrial enzyme that produces hydrogen peroxide (H2O2), increase in several models of cardiomyopathies. Therefore, we hypothesized that an increase in cardiac MAO-A could cause oxidative stress and mitochondrial damage, leading to cardiac dysfunction. In the present study, we evaluated the consequences of cardiac MAO-A augmentation on chronic oxidative damage, cardio-myocyte survival, and heart function, and identified the intracellular pathways involved. Results: We generated transgenic (Tg) mice with cardiac-specific MAO-A overexpression. Tg mice displayed cardiac MAO-A activity levels similar to those found in HF and aging. As expected, Tg mice showed a significant decrease in the cardiac amounts of the MAO-A substrates serotonin and norepinephrine. This was associated with enhanced H2O2 generation in situ and mitochondrial DNA oxidation. As a consequence, MAO-A Tg mice demonstrated progressive loss of cardiomyocytes by necrosis and ventricular failure, which were prevented by chronic treatment with the MAO-A inhibitor clorgyline and the antioxidant N-acetyl-cystein. Interestingly, Tg hearts exhibited p53 accumulation and downregulation of peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha), a master regulator of mitochondrial function. This was concomitant with cardiac mitochondrial ultrastructural defects and ATP depletion. In vitro, MAO-A adenovirus transduction of neonatal cardiomyocytes mimicked the results in MAO-A Tg mice, triggering oxidative stress-dependent p53 activation, leading to PGC-1 alpha downregulation, mitochondrial impairment, and cardiomyocyte necrosis. Innovation and Conclusion: We provide the first evidence that MAO-A upregulation in the heart causes oxidative mitochondrial damage, p53-dependent repression of PGC-1 alpha, cardiomyocyte necrosis, and chronic ventricular dysfunction. Antioxid. Redox Signal. 18, 5-18.Keywords
This publication has 43 references indexed in Scilit:
- Glutathione Peroxidase-1 in Health and Disease: From Molecular Mechanisms to Therapeutic OpportunitiesAntioxidants and Redox Signaling, 2011
- Telomere dysfunction induces metabolic and mitochondrial compromiseNature, 2011
- PGC-1α Regulates Expression of Myocardial Mitochondrial Antioxidants and Myocardial Oxidative Stress After Chronic Systolic OverloadAntioxidants and Redox Signaling, 2010
- Ca 2+ /Calmodulin-Dependent Kinase IIδ Causes Heart Failure by Accumulation of p53 in Dilated CardiomyopathyCirculation, 2010
- Mitochondria in heart failureCardiovascular Research, 2010
- Monoamine Oxidase A–Mediated Enhanced Catabolism of Norepinephrine Contributes to Adverse Remodeling and Pump Failure in Hearts With Pressure OverloadCirculation Research, 2010
- The p53-cathepsin axis cooperates with ROS to activate programmed necrotic death upon DNA damageProceedings of the National Academy of Sciences of the United States of America, 2009
- Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodellingCardiovascular Research, 2008
- Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failureJCI Insight, 2007
- Neurotoxicity and Metabolism of the Catecholamine-Derived 3,4-Dihydroxyphenylacetaldehyde and 3,4-Dihydroxyphenylglycolaldehyde: The Role of Aldehyde DehydrogenasePublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2007